Trials / Completed
CompletedNCT02937233
Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study
A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Kathryn Stephenson · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a phase 1 trial of one or more administrations of Zika Virus Purified Inactivated Vaccine (ZPIV). The trial will be conducted under a placebo controlled, double-blind, randomized allocation of study product. There are four groups in the study. Each group is testing a different vaccine schedule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Zika Virus Purified Inactivated Vaccine | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-12-08
- Primary completion
- 2018-06-04
- Completion
- 2018-06-04
- First posted
- 2016-10-18
- Last updated
- 2018-08-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02937233. Inclusion in this directory is not an endorsement.